GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study ...

A new review published in Sleep Medicine Reviews sheds light on the biological mechanisms that may explain why patients with ...

GLP-1 inhibitors, like tirzepatide, show promise in reducing AHI in OSA patients with obesity, as demonstrated in the SURMOUNT trials. Experts highlight the importance of integrating GLP-1s with diet ...

Combined treatments for both aspects of obstructive sleep apnea (OSA)—a compromised airway anatomy and unstable ...

In patients with obstructive sleep apnea, combining supplemental oxygen with a mandibular advancement device leads to greater ...

The way we diagnose sleep apnea is this surrogate endpoint called the apnea-hypopnea index. But, sometimes, this has very ...

If you're experiencing snoring, daytime fatigue, or morning headaches, don't ignore the signs, it could be sleep apnea! Dr.

Medicare Part B may cover sleep studies, including polysomnographies, to screen for obstructive sleep apnea (OSA) if a person shows clinical signs and their doctor provides medical evidence supporting ...

At the LifeBridge Health ENT Sinus & Allergy Center, Dr. Alpen Patel helps patients get to the root of disrupted sleep. With ...

Anyone can develop obstructive sleep apnea (OSA), but there are certain risk factors that can make some people more susceptible to the condition than others. “Obesity, by far, is the main risk factor, ...